4//SEC Filing
Alexza Pharmaceuticals Inc. 4
Accession 0001209191-16-129011
CIK 0001344413operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 3:52 PM ET
Size
18.5 KB
Accession
0001209191-16-129011
Insider Transaction Report
Form 4
TURNER JOSEPH L
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2016-06-21−2,500→ 0 totalExercise: $28.00From: 2010-08-21Exp: 2020-07-20→ Common Stock (2,500 underlying) - Disposition from Tender
Common Stock
2016-06-21−1,050→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−12,500→ 0 totalExercise: $1.28From: 2016-06-03Exp: 2025-06-02→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−11,606→ 0 totalExercise: $4.68From: 2013-06-21Exp: 2023-05-20→ Common Stock (11,606 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−3,991→ 0 totalExercise: $3.50From: 2012-07-06Exp: 2022-06-06→ Common Stock (3,991 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−3,125→ 0 totalExercise: $15.30From: 2011-08-28Exp: 2021-07-28→ Common Stock (3,125 underlying)
Footnotes (2)
- [F1]Per the terms of the Agreement and Plan of Merger, dated 5/9/16, among the Issuer, Grupo Ferrer Internactional, S.A. and Ferrer Pharma Inc. (the "Agreement) and the Offer (as defined in the Agreement), each share of the Issuer's common stock was tendered for $0.90 per share in cash, without interest and less any required withholding taxes, plus one contractual contingent value right per share ("CVR") (as defined in the Agreement).
- [F2]Disposed of per Section 3.4(a) of the Agreement, whereby each option that was outstanding immediately prior to the Offer Closing (as defined in the Agreement) was cancelled without consideration.
Documents
Issuer
Alexza Pharmaceuticals Inc.
CIK 0001344413
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001344413
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 3:52 PM ET
- Size
- 18.5 KB